KED (Vesugen) is posited to be a short peptide that may act as a cell-regulating bioregulator with actions on differentiation, repair, and functional maintenance in aging cells. The peptide is defined as one of Khavinson’s peptides, and it is studied primarily by the...
Sermorelin and Ipamorelin are research peptides that may have synergistic actions when blended, as they may stimulate the release of growth hormone (hGH) from pituitary cells via complementary pathways. Sermorelin appears to be analogous to the endogenous GHRH, which...
Sermorelin and GHRP-2 are two peptides researched for their potential to stimulate the release of growth hormone (hGH) from pituitary cells. Each of these peptides appears to mediate this potential through a distinct receptor system. Sermorelin appears to interact...
Sermorelin is a research peptide considered to be the shortest functional analog of the endogenous growth hormone-releasing hormone (GHRH). For context, GHRH has a 44 amino acid structure posited to be the main hormone that interacts with the cells responsible for the...
FOXO4-DRI is a synthetic peptide that is actively researched regarding its potential to induce programmed cell death in aged cells, and thus reduce the burden that aged cells pose on different tissues. Apparently, the peptide achieves that by mimicking a part of the...
Palmitoyl Tetrapeptide-7, also referred to as Pal-GQPR, is considered a tetrapeptide that may “stimulate collagen renewal and inhibit collagen degradation” in mammalian models according to the available research.(1) This tetrapeptide is described as a palmitoylated...
